Science Explorer Back to mapMap
Discussion
Institution · Sigmovir Biosystems (United States)

Most cited papers from Sigmovir Biosystems (United States)

Sigmovir Biosystems (United States)

What are the most cited papers from Sigmovir Biosystems (United States)?

The most cited paper from Sigmovir Biosystems (United States) is "Inferring Nonneutral Evolution from Human-Chimp-Mouse Orthologous Gene Trios" (Andrew G. Clark, Stephen Glanowski, Rasmus O. Nielsen et al., 2003), with 683 citations. Next come "The Lyon–Fedder–Mobarry (LFM) global MHD magnetospheric simulation code" (541) and "Use of a Staphylococcus aureus Conjugate Vaccine in Patients Receiving Hemodialysis" (477).

Showing 50 of 56 papers. Every paper with more than 11 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Inferring Nonneutral Evolution from Human-Chimp-Mouse Orthologous Gene Trios Andrew G. Clark, Stephen Glanowski, Rasmus O. Nielsen et al. · Science 11 Dec 2003 683
2 The Lyon–Fedder–Mobarry (LFM) global MHD magnetospheric simulation code John G. Lyon, Joel A. Fedder, Clark M. Mobarry · Journal of Atmospheric and Solar-Terrestrial Physics 10 Sep 2004 541
3 Use of a Staphylococcus aureus Conjugate Vaccine in Patients Receiving Hemodialysis Henry R. Shinefield, STEVEN B. BLACK, Ali Fattom et al. · New England Journal of Medicine Open access 14 Feb 2002 477
4 The TLR4 antagonist Eritoran protects mice from lethal influenza infection Kari Ann Shirey, Wendy Lai, Alison J. Scott et al. · Nature Open access May 2013 424
5 Immunoblotting and Immunodetection Sean R. Gallagher, Scott Winston, Steven A. Fuller et al. · Current Protocols in Immunology Nov 2008 184
6 Optimal Haplotype Block-Free Selection of Tagging SNPs for Genome-Wide Association Studies Bjarni V. Halldórsson, Vineet Bafna, Ross A. Lippert et al. · Genome Research Open access Aug 2004 136
7 TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection Laure Perrin‐Cocon, Anne Aublin‐Gex, Stefania Enza Sestito et al. · Scientific Reports Open access 20 Jan 2017 123
8 Respiratory Syncytial Virus Fusion Protein-Induced Toll-Like Receptor 4 (TLR4) Signaling Is Inhibited by the TLR4 Antagonists Rhodobacter sphaeroides Lipopolysaccharide and Eritoran (E5564) and Requires Direct Interaction with MD-2 Prasad Rallabhandi, Rachel L. Phillips, Marina S. Boukhvalova et al. · mBio Open access 8 Aug 2012 114
9 Estrogen Receptor Genotypes and Haplotypes Associated with Breast Cancer Risk Bert Gold, Francis Kalush, Julie D. Bergeron et al. · Cancer Research 15 Dec 2004 111
10 A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation Christopher C. Stobart et al. · Nature Communications Open access 21 Dec 2016 110
11 Novel Drugs Targeting Toll-Like Receptors for Antiviral Therapy Mira C. Patel, Kari Ann Shirey, Lioubov M. Pletneva et al. · Future Virology Open access Sep 2014 101
12 Expression of the Membrane-Associated Resistance Protein RPW8 Enhances Basal Defense Against Biotrophic Pathogens Wenming Wang, Alessandra Devoto, John G. Turner et al. · Molecular Plant-Microbe Interactions 11 Jul 2007 97
13 Gene and alternative splicing annotation with AIR Liliana Florea, Valentina Di Francesco, Jason Rafe Miller et al. · Genome Research Open access 2005 80
14 Novel strategies for targeting innate immune responses to influenza Kari Ann Shirey, Wendy Lai, Mira C. Patel et al. · Mucosal Immunology Open access 27 Jan 2016 76
15 Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology Kari Ann Shirey, Wendy Lai, Lioubov M. Pletneva et al. · Mucosal Immunology Open access 25 Sep 2013 76
16 Targeting TLR4 Signaling to Blunt Viral-Mediated Acute Lung Injury Kari Ann Shirey, Jorge C. G. Blanco, Stefanie N. Vogel · Frontiers in Immunology Open access 2 Jul 2021 70
17 Influenza “Trains” the Host for Enhanced Susceptibility to Secondary Bacterial Infection Kari Ann Shirey, Darren J. Perkins, Wendy Lai et al. · mBio Open access 6 May 2019 67
18 Optimal Selection of SNP Markers for Disease Association Studies Bjarni V. Halldórsson, Sorin Istrail, Francisco M. De La Vega · Human Heredity 2004 66
19 Early or Late Bacterial Lung Infection Increases Mortality After Traumatic Brain Injury in Male Mice and Chronically Impairs Monocyte Innate Immune Function Sarah J. Doran, Rebecca J. Henry, Kari Ann Shirey et al. · Critical Care Medicine Open access 9 Mar 2020 64
20 Epigenetic Mechanisms Governing Innate Inflammatory Responses Darren J. Perkins, Mira C. Patel, Jorge C. G. Blanco et al. · Journal of Interferon & Cytokine Research Open access Jul 2016 56
21 Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model Jorge C. G. Blanco, Lioubov M. Pletneva, Lori W. McGinnes-Cullen et al. · Nature Communications Open access 9 May 2018 52
22 Chronic Helminth Infection Does Not Exacerbate Mycobacterium tuberculosis Infection Marc Peter Hübner, Kristin E. Killoran, Michael Rajnik et al. · PLoS neglected tropical diseases Open access 20 Dec 2012 51
23 The Cotton Rat Sigmodon Hispidus Model of Respiratory Syncytial Virus Infection Marina S. Boukhvalova, Jorge C. G. Blanco · Current topics in microbiology and immunology Book chapter 2013 49
24 Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy Bette S. Pollard, Jorge C. G. Blanco, John Robert Pollard · In Vivo Open access 2020 47
25 Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections Mira C. Patel, Kari Ann Shirey, Marina S. Boukhvalova et al. · mBio Open access 12 Mar 2018 47
26 A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats Christina A. Rostad, Christopher C. Stobart, Brian E. Gilbert et al. · Journal of Virology Open access 9 Jun 2016 47
27 Prophylactic antibody treatment and intramuscular immunization reduce infectious human rhinovirus 16 load in the lower respiratory tract of challenged cotton rats Jorge C. G. Blanco, Susan B. Core, Lioubov M. Pletneva et al. · Trials in Vaccinology Open access 2014 47
28 Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus Marina BOUKHVALOVA, KC Yim, JCG Blanco · Antiviral chemistry & chemotherapy Open access 2018 44
29 Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus) Mira C. Patel, Wei Wang, Lioubov M. Pletneva et al. · PLoS ONE Open access 4 Nov 2016 41
30 Receptor Characterization and Susceptibility of Cotton Rats to Avian and 2009 Pandemic Influenza Virus Strains Jorge C. G. Blanco, Lioubov M. Pletneva, Hongquan Wan et al. · Journal of Virology Open access 30 Nov 2012 40
31 A recombinant anchorless respiratory syncytial virus (RSV) fusion (F) protein/monophosphoryl lipid A (MPL) vaccine protects against RSV-induced replication and lung pathology Jorge C. G. Blanco, Marina S. Boukhvalova, Lioubov M. Pletneva et al. · Vaccine Open access 16 Nov 2013 40
32 Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein Lori M. Cullen, Jorge C. G. Blanco, Trudy G. Morrison · Journal of Translational Medicine Open access 5 Nov 2015 35
33 A mouse model of human TLR4 D299G/T399I SNPs reveals mechanisms of altered LPS and pathogen responses Katharina Richard, Kurt H. Piepenbrink, Kari Ann Shirey et al. · The Journal of Experimental Medicine Open access 10 Oct 2020 34
34 Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARγ/RXR ligands in IL-4-induced M2a macrophage differentiation Archana Gopalakrishnan, John Joseph, Kari Ann Shirey et al. · Frontiers in Immunology Open access 16 Aug 2022 33
35 Treatment with novel RSV Ig RI-002 controls viral replication and reduces pulmonary damage in immunocompromised Sigmodon hispidus Marina BOUKHVALOVA, Jorge C. G. Blanco, Ann Regina Falsey et al. · Bone Marrow Transplantation Open access 14 Sep 2015 31
36 Herpes Simplex Virus 1 Induces Brain Inflammation and Multifocal Demyelination in the Cotton Rat Sigmodon hispidus Marina S. Boukhvalova, Emma Mortensen, Aissatou Mbaye et al. · Journal of Virology Open access 9 Oct 2019 30
37 A multifaceted approach to RSV vaccination Jorge C. G. Blanco, Marina S. Boukhvalova, Trudy G. Morrison et al. · Human Vaccines & Immunotherapeutics Open access 17 May 2018 30
38 Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model Marina S. Boukhvalova, Jamall McKay, Aissatou Mbaye et al. · Journal of Virology Open access 16 Jul 2015 29
39 Development of an intradermal DNA vaccine delivery strategy to achieve single-dose immunity against respiratory syncytial virus Trevor R.F. Smith, Katherine Schultheis, Matthew P. Morrow et al. · Vaccine Open access 14 Apr 2017 28
40 Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy Jorge C. G. Blanco, Lioubov M. Pletneva, Raymonde O. Oue et al. · Vaccine Open access 31 Aug 2015 27
41 Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues Christina A. Rostad, Christopher C. Stobart, Sean O. Todd et al. · Journal of Virology Open access 19 Dec 2017 25
42 Mutation of Respiratory Syncytial Virus G Protein’s CX3C Motif Attenuates Infection in Cotton Rats and Primary Human Airway Epithelial Cells Binh Ha, Tatiana Chirkova, Marina S. Boukhvalova et al. · Vaccines Open access 19 Jul 2019 23
43 Modeling Human Respiratory Viral Infections in the Cotton Rat (Sigmodon hispidus) Jorge C. G. Blanco · Journal of Antivirals & Antiretrovirals Open access 2014 22
44 Cotton rat lung transcriptome reveals host immune response to Respiratory Syncytial Virus infection Seesandra V. Rajagopala, Harinder Singh, Mira C. Patel et al. · Scientific Reports Open access 23 Jul 2018 21
45 Vaccination of Seropositive Subjects with CHIRON CMV gB Subunit Vaccine Combined with MF59 Adjuvant for Production of CMV Immune Globulin Murray Drulak, Frank J. Malinoski, Steven A. Fuller et al. · Viral Immunology 2000 18
46 Preclinical assessment of safety of maternal vaccination against respiratory syncytial virus (RSV) in cotton rats Jorge C. G. Blanco, Lioubov M. Pletneva, Raymonde O. Otoa et al. · Vaccine Open access 16 Jun 2017 17
47 Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus Jorge C. G. Blanco, Lurds R. Fernando, Wei Zhang et al. · Journal of Virology Open access 9 Sep 2019 16
48 Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection Kari Ann Shirey, Mary E. Sunday, Wendy Lai et al. · Mucosal Immunology Open access 16 Oct 2018 16
49 Select targeting of intracellular Toll-interleukin-1 receptor resistance domains for protection against influenza-induced disease Kari Ann Shirey, Wendy Lai, Lindsey J. Brown et al. · Innate Immunity Open access 2020 15
50 Enhanced allergic responsiveness after early childhood infection with respiratory viruses: Are long-lived alternatively activated macrophages the missing link? Achsah Dorsey Keegan, Kari Ann Shirey, Dayanand N. Bagdure et al. · Pathogens and Disease Open access 12 May 2016 15

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.